| 45802-402-65 |
45802-402 |
HUMAN PRESCRIPTION DRUG |
Alogliptin and Pioglitazone |
Alogliptin Benzoate and Pioglitazone hydrochloride |
TABLET, FILM COATED |
ORAL |
20160408 |
N/A |
NDA AUTHORIZED GENERIC |
NDA022426 |
Padagis Israel Pharmaceuticals Ltd |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
25 mg/1; 30 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE (45802-402-65) |
| 45802-260-65 |
45802-260 |
HUMAN PRESCRIPTION DRUG |
Alogliptin and Pioglitazone |
Alogliptin Benzoate and Pioglitazone hydrochloride |
TABLET, FILM COATED |
ORAL |
20160408 |
N/A |
NDA AUTHORIZED GENERIC |
NDA022426 |
Padagis Israel Pharmaceuticals Ltd |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
12.5 mg/1; 30 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE (45802-260-65) |
| 64764-253-03 |
64764-253 |
HUMAN PRESCRIPTION DRUG |
OSENI |
alogliptin and pioglitazone |
TABLET, FILM COATED |
ORAL |
20130125 |
N/A |
NDA |
NDA022426 |
Takeda Pharmaceuticals America, Inc. |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
25 mg/1; 30 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE (64764-253-03) |
| 64764-253-04 |
64764-253 |
HUMAN PRESCRIPTION DRUG |
OSENI |
alogliptin and pioglitazone |
TABLET, FILM COATED |
ORAL |
20130125 |
N/A |
NDA |
NDA022426 |
Takeda Pharmaceuticals America, Inc. |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
25 mg/1; 30 mg/1 |
90 TABLET, FILM COATED in 1 BOTTLE (64764-253-04) |
| 64764-253-05 |
64764-253 |
HUMAN PRESCRIPTION DRUG |
OSENI |
alogliptin and pioglitazone |
TABLET, FILM COATED |
ORAL |
20130125 |
N/A |
NDA |
NDA022426 |
Takeda Pharmaceuticals America, Inc. |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
25 mg/1; 30 mg/1 |
500 TABLET, FILM COATED in 1 BOTTLE (64764-253-05) |
| 45802-499-65 |
45802-499 |
HUMAN PRESCRIPTION DRUG |
Alogliptin and Pioglitazone |
Alogliptin Benzoate and Pioglitazone hydrochloride |
TABLET, FILM COATED |
ORAL |
20160408 |
N/A |
NDA AUTHORIZED GENERIC |
NDA022426 |
Padagis Israel Pharmaceuticals Ltd |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
25 mg/1; 45 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE (45802-499-65) |
| 45802-351-65 |
45802-351 |
HUMAN PRESCRIPTION DRUG |
Alogliptin and Pioglitazone |
Alogliptin Benzoate and Pioglitazone hydrochloride |
TABLET, FILM COATED |
ORAL |
20160408 |
N/A |
NDA AUTHORIZED GENERIC |
NDA022426 |
Padagis Israel Pharmaceuticals Ltd |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
25 mg/1; 15 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE (45802-351-65) |
| 64764-254-03 |
64764-254 |
HUMAN PRESCRIPTION DRUG |
OSENI |
alogliptin and pioglitazone |
TABLET, FILM COATED |
ORAL |
20130125 |
N/A |
NDA |
NDA022426 |
Takeda Pharmaceuticals America, Inc. |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
25 mg/1; 45 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE (64764-254-03) |
| 64764-254-04 |
64764-254 |
HUMAN PRESCRIPTION DRUG |
OSENI |
alogliptin and pioglitazone |
TABLET, FILM COATED |
ORAL |
20130125 |
N/A |
NDA |
NDA022426 |
Takeda Pharmaceuticals America, Inc. |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
25 mg/1; 45 mg/1 |
90 TABLET, FILM COATED in 1 BOTTLE (64764-254-04) |
| 64764-254-05 |
64764-254 |
HUMAN PRESCRIPTION DRUG |
OSENI |
alogliptin and pioglitazone |
TABLET, FILM COATED |
ORAL |
20130125 |
N/A |
NDA |
NDA022426 |
Takeda Pharmaceuticals America, Inc. |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
25 mg/1; 45 mg/1 |
500 TABLET, FILM COATED in 1 BOTTLE (64764-254-05) |
| 64764-251-03 |
64764-251 |
HUMAN PRESCRIPTION DRUG |
OSENI |
alogliptin and pioglitazone |
TABLET, FILM COATED |
ORAL |
20130125 |
N/A |
NDA |
NDA022426 |
Takeda Pharmaceuticals America, Inc. |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
25 mg/1; 15 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE (64764-251-03) |
| 64764-251-04 |
64764-251 |
HUMAN PRESCRIPTION DRUG |
OSENI |
alogliptin and pioglitazone |
TABLET, FILM COATED |
ORAL |
20130125 |
N/A |
NDA |
NDA022426 |
Takeda Pharmaceuticals America, Inc. |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
25 mg/1; 15 mg/1 |
90 TABLET, FILM COATED in 1 BOTTLE (64764-251-04) |
| 64764-251-05 |
64764-251 |
HUMAN PRESCRIPTION DRUG |
OSENI |
alogliptin and pioglitazone |
TABLET, FILM COATED |
ORAL |
20130125 |
N/A |
NDA |
NDA022426 |
Takeda Pharmaceuticals America, Inc. |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
25 mg/1; 15 mg/1 |
500 TABLET, FILM COATED in 1 BOTTLE (64764-251-05) |
| 64764-123-03 |
64764-123 |
HUMAN PRESCRIPTION DRUG |
OSENI |
alogliptin and pioglitazone |
TABLET, FILM COATED |
ORAL |
20130125 |
N/A |
NDA |
NDA022426 |
Takeda Pharmaceuticals America, Inc. |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
12.5 mg/1; 30 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE (64764-123-03) |
| 64764-123-04 |
64764-123 |
HUMAN PRESCRIPTION DRUG |
OSENI |
alogliptin and pioglitazone |
TABLET, FILM COATED |
ORAL |
20130125 |
N/A |
NDA |
NDA022426 |
Takeda Pharmaceuticals America, Inc. |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
12.5 mg/1; 30 mg/1 |
90 TABLET, FILM COATED in 1 BOTTLE (64764-123-04) |
| 64764-123-05 |
64764-123 |
HUMAN PRESCRIPTION DRUG |
OSENI |
alogliptin and pioglitazone |
TABLET, FILM COATED |
ORAL |
20130125 |
N/A |
NDA |
NDA022426 |
Takeda Pharmaceuticals America, Inc. |
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE |
12.5 mg/1; 30 mg/1 |
500 TABLET, FILM COATED in 1 BOTTLE (64764-123-05) |